INTRATUMORAL EXPRESSION OF PD-1/PD-L1 IMMUNE CHECKPOINT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

被引：0
作者：
Baquerizo, Angeles [1 ,2 ]
Vavinskaya, Vera [3 ]
Rojas, Angela [4 ]
Mhoyan, Anna [5 ]
Romero-Gomez, Manuel [6 ]
Sher, Linda [7 ]
Madani, Bahar [2 ]
Fisher, Jonathan [1 ]
Schaffer, Randolph [1 ]
Frenette, Catherine T. [8 ]
Marsh, Christopher [9 ]
机构：
[1] Scripps Hlth, Surg, La Jolla, CA USA
[2] Scripps Clin, La Jolla, CA 92037 USA
[3] UCSD, Pathol, La Jolla, CA USA
[4] Virgen Del Rocio Univ Hosp, Hepatol, Seville, Spain
[5] Kaiser, Pathol, San Diego, CA USA
[6] Virgen Del Rocio Univ Hosp, Seville, Spain
[7] USC, Los Angeles, CA USA
[8] Scripps Hlth, Scripps Clin, La Jolla, CA USA
[9] Scripps Hlth, La Jolla, CA USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
321
引用
收藏
页码：206A / 206A
页数：1
相关论文
共 50 条
  • [21] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [22] Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors for Advanced NSCLC According to PD-L1 Expression: A Meta-Analysis
    Ma, K.
    Guo, Y.
    Wang, Y.
    Wang, X.
    Xu, Y.
    Sun, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S584 - S584
  • [23] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [24] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Baraibar, Iosune
    Melero, Ignacio
    Ponz-Sarvise, Mariano
    Castanon, Eduardo
    DRUG SAFETY, 2019, 42 (02) : 281 - 294
  • [25] Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction
    Le Biannic, Raphael
    Magnez, Romain
    Klupsch, Frederique
    Leleu-Chavain, Natascha
    Thiroux, Bryan
    Tardy, Morgane
    El Bouazzati, Hassiba
    Dezitter, Xavier
    Renault, Nicolas
    Vergoten, Gerard
    Bailly, Christian
    Quesnel, Bruno
    Thuru, Xavier
    Millet, Regis
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [26] Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
    Sharma, Meenal
    Yang, Zhiming
    Miyamoto, Hiroshi
    MEDICINE, 2019, 98 (38)
  • [27] Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma
    Owen, Dwight
    Chu, Benjamin
    Lehman, Amy M.
    Annamalai, Lakshmanan
    Yearley, Jennifer H.
    Shilo, Konstantin
    Otterson, Gregory A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : 1204 - 1212
  • [28] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [29] POTENTIAL AS BIOMARKERS OF SOLUBLE PD-1 AND PD-L1 IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Kato, Naoya
    HEPATOLOGY, 2019, 70 : 1218A - 1218A
  • [30] PD-1/PD-L1 checkpoint in hematological malignancies
    Annibali, O.
    Crescenzi, A.
    Tomarchio, V.
    Pagano, A.
    Bianchi, A.
    Grifoni, A.
    Avvisati, G.
    LEUKEMIA RESEARCH, 2018, 67 : 45 - 55
12345